| Diffusion-weighted MRI in the body: applications and challenges in oncology DM Koh, DJ Collins American Journal of Roentgenology 188 (6), 1622-1635, 2007 | 2675 | 2007 |
| Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations AR Padhani, G Liu, D Mu-Koh, TL Chenevert, HC Thoeny, T Takahara, ... Neoplasia 11 (2), 102-125, 2009 | 2379 | 2009 |
| Patient-derived organoids model treatment response of metastatic gastrointestinal cancers G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ... Science 359 (6378), 920-926, 2018 | 1620 | 2018 |
| Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges DM Koh, DJ Collins, MR Orton American Journal of Roentgenology 196 (6), 1351-1361, 2011 | 671 | 2011 |
| Stacked autoencoders for unsupervised feature learning and multiple organ detection in a pilot study using 4D patient data HC Shin, MR Orton, DJ Collins, SJ Doran, MO Leach IEEE transactions on pattern analysis and machine intelligence 35 (8), 1930-1943, 2012 | 602 | 2012 |
| Technology insight: water diffusion MRI—a potential new biomarker of response to cancer therapy DM Patterson, AR Padhani, DJ Collins Nature clinical practice Oncology 5 (4), 220-233, 2008 | 459 | 2008 |
| Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients DM Koh, E Scurr, D Collins, B Kanber, A Norman, MO Leach, JE Husband American Journal of Roentgenology 188 (4), 1001-1008, 2007 | 443 | 2007 |
| Whole-body diffusion-weighted MR imaging in cancer: current status and research directions AR Padhani, DM Koh, DJ Collins Radiology 261 (3), 700-718, 2011 | 412 | 2011 |
| Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and … A Andreou, DM Koh, DJ Collins, M Blackledge, T Wallace, MO Leach, ... European radiology 23, 428-434, 2013 | 346 | 2013 |
| Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer MLW Ah-See, A Makris, NJ Taylor, M Harrison, PI Richman, RJ Burcombe, ... Clinical Cancer Research 14 (20), 6580-6589, 2008 | 330 | 2008 |
| METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based … AR Padhani, FE Lecouvet, N Tunariu, DM Koh, F De Keyzer, DJ Collins, ... European urology 71 (1), 81-92, 2017 | 304 | 2017 |
| Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging—value of histogram analysis of apparent diffusion coefficients S Kyriazi, DJ Collins, C Messiou, K Pennert, RL Davidson, SL Giles, ... Radiology 261 (1), 182-192, 2011 | 275 | 2011 |
| Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body DM Koh, T Takahara, Y Imai, DJ Collins Magnetic Resonance in Medical Sciences 6 (4), 211-224, 2007 | 272 | 2007 |
| Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS) C Messiou, J Hillengass, S Delorme, FE Lecouvet, LA Moulopoulos, ... Radiology 291 (1), 5-13, 2019 | 257 | 2019 |
| Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma SL Giles, C Messiou, DJ Collins, VA Morgan, CJ Simpkin, S West, ... Radiology 271 (3), 785-794, 2014 | 226 | 2014 |
| Computed diffusion-weighted MR imaging may improve tumor detection MD Blackledge, MO Leach, DJ Collins, DM Koh Radiology 261 (2), 573-581, 2011 | 225 | 2011 |
| Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies TA Yap, D Olmos, AT Brunetto, N Tunariu, J Barriuso, R Riisnaes, L Pope, ... Journal of Clinical Oncology 29 (10), 1271-1279, 2011 | 222 | 2011 |
| Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls DM Koh, M Blackledge, AR Padhani, T Takahara, TC Kwee, MO Leach, ... American Journal of Roentgenology 199 (2), 252-262, 2012 | 221 | 2012 |
| Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry—initial observations PJ Hoskin, DM Carnell, NJ Taylor, RE Smith, JJ Stirling, FM Daley, ... International Journal of Radiation Oncology* Biology* Physics 68 (4), 1065-1071, 2007 | 213 | 2007 |
| Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer P Nathan, M Zweifel, AR Padhani, DM Koh, M Ng, DJ Collins, A Harris, ... Clinical Cancer Research 18 (12), 3428-3439, 2012 | 211 | 2012 |
Dow-Mu KohProfessor in Functional Cancer Imaging, Royal Marsden Hospital & Institute of Cancer Research在 icr.ac.uk 的电子邮件经过验证
